A gluco-mindful approach to diabetic gastroparesis

J Pak Med Assoc. 2024 Feb;74(2):398-399. doi: 10.47391/JPMA.24-08.

Abstract

Diabetes gastroparesis is a common manifestation of autonomic neuropathy in persons with long-standing, uncontrolled diabetes. Most discussion about its management revolves around the mitigation of symptoms. Here, we share tips on choosing the right glucose-lowering medication, based upon predominant symptomatology of gastroparesis. We highlight about insulin preparations, and their timing of administration, can be tailored according to need. We also emphasize the need to choose oral glucose lowering drugs with care.

Keywords: FI Asp, GLP1RA, modern sulfonylureas, person-centred care, SGLTi, tirzepatide, URLi..

MeSH terms

  • Diabetes Mellitus* / drug therapy
  • Diabetic Neuropathies* / complications
  • Diabetic Neuropathies* / drug therapy
  • Gastroparesis* / diagnosis
  • Gastroparesis* / etiology
  • Gastroparesis* / therapy
  • Glucose
  • Humans
  • Insulin / therapeutic use

Substances

  • Glucose
  • Insulin